Insights

Strategic Partnerships BenchSci is actively expanding its AI-driven preclinical capabilities through high-profile collaborations with Argenx, Merck, Sanofi, Mila, Thermo Fisher Scientific, and Thermo Fisher collaboration efforts. These partnerships indicate a receptive market for scalable AI tools in drug discovery, presenting opportunities to position complementary analytics, data integration, and workflow automation solutions to supportive stakeholders within these accounts.

Enterprise Licensing Recent multi-year and three-year license agreements with Sanofi and Thermo Fisher highlight a strong enterprise sales motion and willingness to commit long-term platforms. This suggests a path for upsell and cross-sell of ASCEND and related AI capabilities to additional global pharma customers seeking platform-level preclinical tooling with governance and security requirements.

Global Growth BenchSci operates as a remote-first, globally deployed platform with customers spanning 16 of the top-20 pharma companies and 4,300 research centers. This broad footprint signals opportunities to target multinational R&D organizations seeking scalable, cloud-native AI solutions that support dispersed teams and compliant data handling.

AI-Driven Value With a focus on AI-enabled preclinical drug discovery and integrations across multiple life sciences tools, BenchSci presents a compelling fit for vendors offering complementary AI data orchestration, model governance, and secure data exchange to accelerate scientific workflows and reduce time-to-insight.

Scale and Security The platform already supports large-scale pharma deployments and enterprise agreements, indicating a buyer preference for robust security, compliance, and performance. This creates opportunities to pitch solutions around data lineage, access controls, and seamless integration with existing IT ecosystems for prospective customers seeking enterprise-grade AI capabilities.

Similar companies to BenchSci

BenchSci Tech Stack

BenchSci uses 8 technology products and services including Apache Spark, Tableau, PostgreSQL, and more. Explore BenchSci's tech stack below.

Media & News

BenchSci's Email Address Formats

BenchSci uses at least 3 email formats:
BenchSci Email FormatsExamplePercentage
FLast@benchsci.comJDoe@benchsci.com
87%
First@benchsci.comJohn@benchsci.com
12%
FMiddleLast@benchsci.comJMichaelDoe@benchsci.com
1%

Frequently Asked Questions

What is BenchSci's official website and social media links?

Minus sign iconPlus sign icon
BenchSci's official website is benchsci.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does BenchSci generate?

Minus sign iconPlus sign icon
As of October 2026, BenchSci's annual revenue is estimated to be $50M - $100M.

What is BenchSci's NAICS code?

Minus sign iconPlus sign icon
BenchSci's NAICS code is 5112 - Software Publishers.

How many employees does BenchSci have currently?

Minus sign iconPlus sign icon
As of October 2026, BenchSci has approximately 203 employees across 4 continents, including North America, Europe and Asia. Key team members include Chief Financial Officer: B. K., Chief Data Officer: E. W. and Chief Of Staff: C. P. Explore BenchSci's employee directory with LeadIQ.

What industry does BenchSci belong to?

Minus sign iconPlus sign icon
BenchSci operates in the Software Development industry.

What technology does BenchSci use?

Minus sign iconPlus sign icon
BenchSci's tech stack includes Apache Spark, Tableau, PostgreSQL, Google Workspace, Atlassian Jira, DocuSign, Cursor Code Editor and Zoom.

What is BenchSci's email format?

Minus sign iconPlus sign icon
BenchSci's email format typically follows the pattern of FLast@benchsci.com. Find more BenchSci email formats with LeadIQ.

How much funding has BenchSci raised to date?

Minus sign iconPlus sign icon
As of October 2026, BenchSci has raised $164M in funding. The last funding round occurred on May 25, 2023 for $70M.

When was BenchSci founded?

Minus sign iconPlus sign icon
BenchSci was founded in 2015.
BenchSci logo

BenchSci

Software DevelopmentOntario, Canada201-500 Employees

BenchSci is a software development company that provides biomedical AI-enabled tools to accelerate life-saving research. Its platform helps scientists perform research faster and with higher quality by applying advanced AI to biomedical data. The company reports broad adoption, including 16 of the top-20 pharmaceutical firms and more than 4,300 leading research centers worldwide.

Based in Toronto, Ontario, the company operates as a remote-first organization and has been recognized for its impact and culture, including Deloitte Tech Fast 50, CIX Top 10 Growth, and Great Place to Work listings. In 2025, it announced a partnership with Sanofi to license its ASCEND platform for drug discovery.

Section iconCompany Overview

NAICS Code
5112 - Software Publishers
Founded
2015
Employees
201-500

Section iconFunding & Financials

  • $164M

    BenchSci has raised a total of $164M of funding over 10 rounds. Their latest funding round was raised on May 25, 2023 in the amount of $70M as a Series D.

  • $50M - $100M

    BenchSci's revenue is estimated to be in the range of $50M - $100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.